Come up with a name for your new list and we'll add to it:
Omrix raised a round of funding on October 23, 1998. Investors include
Thuja Capital Management.
Omrix is a fully integrated biopharmaceutical company that develops, manufactures and markets protein-based biosurgery and passive immunotherapy products. Omrix's biosurgery product line includes prod…